You can’t afford to miss this one

Reducing Hospital
Liability for a Common
Source of Malpractice

Thursday, September 9th, 2021
1:00 PM – 2:00 PM EST

Sponsored by:

ivwatch logo
Registration Form
x

Loading
Page 1

In this webinar you will learn to:

In this webinar you
will learn to:

Identify the risks, causes, standards, costs and potential legal liabilities for IV infiltration/extravasation events.

Explain the legal basis for IV infiltration/extravasation negligence claims and why they are often successfully awarded in favor of the patient, and ultimately leave a long-lasting negative stigma for a hospital.

Discuss why technology that provides continuous IV monitoring can mitigate harm associated with infiltration/extravasation, reduce provider liability and costs, and aligns with the evidence-based standard of care.

Featuring:

Speaker: Russell Nassof, JD

Mr. Nassof is an attorney who has been involved in the fields of health risk consulting and clinical education for over 25 years concentrating his work in the areas of infection prevention, and risk/liability minimization for healthcare and environmental risk.

He has presented to legal, insurance, loss control, healthcare, and risk management groups throughout the world including presentations at CDC and WHO.

Mr. Nassof has been involved as a consulting/testifying expert on numerous high profile environmental events and infection outbreaks. He has served as both the Treasurer and Secretary of the Association for Vascular Access (AVA) and has been a reviewer on the 2016/2021 INS Standards of Practice.

Mr. Nassof received his Juris Doctorate and undergraduate degrees from Emory University in Atlanta.

Speaker: Russell Nassof, JD

Mr. Nassof is an attorney who has been involved in the fields of health risk consulting and clinical education for over 25 years concentrating his work in the areas of infection prevention, and risk/liability minimization for healthcare and environmental risk.

He has presented to legal, insurance, loss control, healthcare, and risk management groups throughout the world including presentations at CDC and WHO.

Mr. Nassof has been involved as a consulting/testifying expert on numerous high profile environmental events and infection outbreaks. He has served as both the Treasurer and Secretary of the Association for Vascular Access (AVA) and has been a reviewer on the 2016/2021 INS Standards of Practice.

Mr. Nassof received his Juris Doctorate and undergraduate degrees from Emory University in Atlanta.

Speaker: Russell Nassof, JD

Mr. Nassof is an attorney who has been involved in the fields of health risk consulting and clinical education for over 25 years concentrating his work in the areas of infection prevention, and risk/liability minimization for healthcare and environmental risk.

He has presented to legal, insurance, loss control, healthcare, and risk management groups throughout the world including presentations at CDC and WHO.

Mr. Nassof has been involved as a consulting/testifying expert on numerous high profile environmental events and infection outbreaks. He has served as both the Treasurer and Secretary of the Association for Vascular Access (AVA) and has been a reviewer on the 2016/2021 INS Standards of Practice.

Mr. Nassof received his Juris Doctorate and undergraduate degrees from Emory University in Atlanta.

Moderator: Gary Warren
President & CEO, ivWatch

Mr. Warren currently serves as President and CEO of ivWatch and has championed the development of non-invasive biosensors that fulfill a huge patient safety need in healthcare. Starting ivWatch in 2010, Mr. Warren assembled a team of leading scientists, clinicians, hospitals, and investors to solve a common drug delivery problem of IV infiltration and extravasation.

He has guided ivWatch through multiple regulatory agency submissions and audits of products for this breakthrough technology with ivWatch products now sold globally. With decades of experience in high-technology companies such as NASA and Symantec, Mr. Warren has a proven track record of creating successful organizations in rapidly emerging markets.

Over his career, he has had executive experience in developing and managing high-growth technologies and venture-backed private companies with a focus on product management and delivery in small start-up companies, large public companies, and government programs.

Speaker: Russell Nassof, JD

Mr. Nassof is an attorney who has been involved in the fields of health risk consulting and clinical education for over 25 years concentrating his work in the areas of infection prevention, and risk/liability minimization for healthcare and environmental risk.

He has presented to legal, insurance, loss control, healthcare, and risk management groups throughout the world including presentations at CDC and WHO.

Mr. Nassof has been involved as a consulting/testifying expert on numerous high profile environmental events and infection outbreaks. He has served as both the Treasurer and Secretary of the Association for Vascular Access (AVA) and has been a reviewer on the 2016/2021 INS Standards of Practice.

Mr. Nassof received his Juris Doctorate and undergraduate degrees from Emory University in Atlanta.

Moderator: Gary Warren President & CEO, ivWatch

Mr. Warren currently serves as President and CEO of ivWatch and has championed the development of non-invasive biosensors that fulfill a huge patient safety need in healthcare. Starting ivWatch in 2010, Mr. Warren assembled a team of leading scientists, clinicians, hospitals, and investors to solve a common drug delivery problem of IV infiltration and extravasation.

He has guided ivWatch through multiple regulatory agency submissions and audits of products for this breakthrough technology with ivWatch products now sold globally. With decades of experience in high-technology companies such as NASA and Symantec, Mr. Warren has a proven track record of creating successful organizations in rapidly emerging markets.

Over his career, he has had executive experience in developing and managing high-growth technologies and venture-backed private companies with a focus on product management and delivery in small start-up companies, large public companies, and government programs.

 

More about the session:

Infiltration/extravasation are common risks of IV therapy, which can result in serious harm, increased morbidity, costs, and liability.

While infiltration/extravasation occurrence does not automatically imply negligence on the part of the provider, there is ample case law and judgments for negligence/malpractice based upon the failure to promptly identify, monitor, and appropriately respond to these issues when they occur.

Both clinical practice guidelines (INS/ONS Standards) and evidence-based medicine require the clinician to carefully monitor patients receiving IV therapy. However, infiltration/extravasation may be difficult (even for the most competent/experienced clinician) to identify before painful symptoms occur.

Technology providing continuous patient IV site monitoring, alerts for infiltration/extravasation with a high degree of accuracy, and a documented record is an important adjunct to clinician assessment. Such technology can potentially reduce patient harm, provider litigation, and associated costs.

Have a question? Contact us: Events@ivWatch.com